Research ArticleClinical Studies
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer
TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
Anticancer Research February 2022, 42 (2) 1065-1071; DOI: https://doi.org/10.21873/anticanres.15568
TAKAFUMI SHIMADA
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
KOUJI IZUMI
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
HIROSHI KANO
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
SUGURU KADOMOTO
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
TOMOYUKI MAKINO
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
RENATO NAITO
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
HIROAKI IWAMOTO
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
HIROSHI YAEGASHI
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
YOSHIFUMI KADONO
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
ATSUSHI MIZOKAMI
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Anticancer Research
Vol. 42, Issue 2
February 2022
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer
TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO, ATSUSHI MIZOKAMI
Anticancer Research Feb 2022, 42 (2) 1065-1071; DOI: 10.21873/anticanres.15568
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer
TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO, ATSUSHI MIZOKAMI
Anticancer Research Feb 2022, 42 (2) 1065-1071; DOI: 10.21873/anticanres.15568
Jump to section
Related Articles
- No related articles found.